Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Neurosci ; 40(15): 3119-3129, 2020 04 08.
Artigo em Inglês | MEDLINE | ID: mdl-32144179

RESUMO

Mitochondrial fission catalyzed by dynamin-related protein 1 (Drp1) is necessary for mitochondrial biogenesis and maintenance of healthy mitochondria. However, excessive fission has been associated with multiple neurodegenerative disorders, and we recently reported that mice with smaller mitochondria are sensitized to ischemic stroke injury. Although pharmacological Drp1 inhibition has been put forward as neuroprotective, the specificity and mechanism of the inhibitor used is controversial. Here, we provide genetic evidence that Drp1 inhibition is neuroprotective. Drp1 is activated by dephosphorylation of an inhibitory phosphorylation site, Ser637. We identify Bß2, a mitochondria-localized protein phosphatase 2A (PP2A) regulatory subunit, as a neuron-specific Drp1 activator in vivo Bß2 KO mice of both sexes display elongated mitochondria in neurons and are protected from cerebral ischemic injury. Functionally, deletion of Bß2 and maintained Drp1 Ser637 phosphorylation improved mitochondrial respiratory capacity, Ca2+ homeostasis, and attenuated superoxide production in response to ischemia and excitotoxicity in vitro and ex vivo Last, deletion of Bß2 rescued excessive stroke damage associated with dephosphorylation of Drp1 S637 and mitochondrial fission. These results indicate that the state of mitochondrial connectivity and PP2A/Bß2-mediated dephosphorylation of Drp1 play a critical role in determining the severity of cerebral ischemic injury. Therefore, Bß2 may represent a target for prophylactic neuroprotective therapy in populations at high risk of stroke.SIGNIFICANCE STATEMENT With recent advances in clinical practice including mechanical thrombectomy up to 24 h after the ischemic event, there is resurgent interest in neuroprotective stroke therapies. In this study, we demonstrate reduced stroke damage in the brain of mice lacking the Bß2 regulatory subunit of protein phosphatase 2A, which we have shown previously acts as a positive regulator of the mitochondrial fission enzyme dynamin-related protein 1 (Drp1). Importantly, we provide evidence that deletion of Bß2 can rescue excessive ischemic damage in mice lacking the mitochondrial PKA scaffold AKAP1, apparently via opposing effects on Drp1 S637 phosphorylation. These results highlight reversible phosphorylation in bidirectional regulation of Drp1 activity and identify Bß2 as a potential pharmacological target to protect the brain from stroke injury.


Assuntos
Isquemia Encefálica/genética , Isquemia Encefálica/prevenção & controle , Dinaminas/genética , Neurônios/metabolismo , Animais , Cálcio/metabolismo , Dinaminas/metabolismo , Feminino , Homeostase , Infarto da Artéria Cerebral Média/genética , Infarto da Artéria Cerebral Média/patologia , Masculino , Camundongos , Camundongos Knockout , Mitocôndrias/metabolismo , Fosforilação , Cultura Primária de Células , Proteína Fosfatase 2/genética , Acidente Vascular Cerebral/patologia , Acidente Vascular Cerebral/prevenção & controle , Superóxidos/metabolismo
2.
J Androl ; 31(3): 235-43, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-19959826

RESUMO

The androgen receptor (AR), a member of the nuclear receptor superfamily, is a ligand-dependent transcription factor involved in regulating expression of an array of androgen-responsive genes. AR-mediated androgen actions play the important roles in male and female reproductive development and function. AR mutations can cause a diverse range of diseases, such as testicular feminization mutation (Tfm) syndrome, prostate cancer, and Kennedy's disease. However, because of a lack of genetic models, the molecular mechanisms involved in the physiological and pathological effects of androgen-AR function in male and female reproductive health remains largely unknown. To get a better insight into the molecular working mechanisms of the AR, a global and several cell-specific conditional knockout mouse models have been developed. These models are reviewed here, and the phenotypes of the different cell-specific androgen receptor knockout (ARKO) mice are compared with those of the global ARKO mice.


Assuntos
Receptores Androgênicos/fisiologia , Animais , Feminino , Genitália Masculina/anatomia & histologia , Masculino , Camundongos , Camundongos Knockout , Fenótipo , Células de Sertoli/fisiologia
3.
Proc Natl Acad Sci U S A ; 101(31): 11209-14, 2004 Aug 03.
Artigo em Inglês | MEDLINE | ID: mdl-15277682

RESUMO

The roles of the androgen receptor (AR) in female fertility and ovarian function remain largely unknown. Here we report on the generation of female mice lacking AR (AR(-/-)) and the resulting influences on the reproductive system. Female AR(-/-) mice appear normal but show longer estrous cycles and reduced fertility. The ovaries from sexually mature AR(-/-) females exhibited a marked reduction in the number of corpora lutea. After superovulation treatment, the AR(-/-) ovaries produced fewer oocytes and also showed fewer corpora lutea. During the periovulatory period, an intensive granulosa apoptosis event occurs in the AR(-/-) preovulatory follicles, concurrent with the down-regulation of p21 and progesterone receptor expression. Furthermore, the defective conformation of the cumulus cell-oocyte complex from the AR(-/-) females implies a lower fertilization capability of the AR(-/-) oocytes. In addition to insufficient progesterone production, the diminished endometrial growth in uteri in response to exogenous gonadotropins indicates that AR(-/-) females exhibit a luteal phase defect. Taken together, these data provide in vivo evidence showing that AR plays an important role in female reproduction.


Assuntos
Infertilidade Feminina/patologia , Infertilidade Feminina/fisiopatologia , Folículo Ovariano/anormalidades , Receptores Androgênicos/genética , Animais , Apoptose , Feminino , Regulação da Expressão Gênica no Desenvolvimento , Marcação In Situ das Extremidades Cortadas , Camundongos , Camundongos Mutantes , Folículo Ovariano/patologia , Fenótipo , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Superovulação/fisiologia , Útero/fisiologia
4.
Contraception ; 66(5): 377-82, 2002 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-12443970

RESUMO

Hsp70-2 functions as a molecular chaperone that assists other proteins in their folding, transport and assembly into complexes, and is postulated to be linked to the mechanisms that inhibit apoptosis. Here we have determined the association between Hsp70-2 gene and germ cell apoptosis induced by a high dose of testosterone undecanoate (TU). In this study, in situ analysis of cell DNA fragmentation and expression of Hsp70-2 in TU-treated monkey testes were compared with the normal testes. The TUNEL analysis data showed that a large number of germ cell apoptosis occurred in the testes on Day 30 after TU injection. Therefore, we speculate that spermatogenesis failure in TU-treated monkey testis may be a result of the germ cell apoptosis induced by a high dose of TU. As compared with that of normal testes, however, the level of Hsp70-2 mRNA was only slightly decreased while that of Hsp70-2 protein was almost unchanged in the testes from Day 7 to day 30 at the early stage of the germ cell apoptosis after TU treatment, but the levels of both Hsp70-2 mRNA and protein dropped dramatically on Day 60 when a large number of germ cells had undergone apoptosis and were depleted. Therefore, it is suggested that the Hsp70-2 may be not a molecule to prevent germ cell apoptosis induced by injection of TU in the testes at the early stage.


Assuntos
Anticoncepcionais Masculinos/farmacologia , Células Germinativas/metabolismo , Proteínas de Choque Térmico HSP70/metabolismo , Testículo/metabolismo , Testosterona/análogos & derivados , Testosterona/farmacologia , Animais , Apoptose , Northern Blotting , Anticoncepcionais Masculinos/administração & dosagem , Fragmentação do DNA , Células Germinativas/efeitos dos fármacos , Proteínas de Choque Térmico HSP70/genética , Imuno-Histoquímica , Marcação In Situ das Extremidades Cortadas , Injeções Intramusculares , Macaca mulatta , Masculino , RNA Mensageiro/genética , Testículo/efeitos dos fármacos , Testosterona/administração & dosagem
5.
Proc Natl Acad Sci U S A ; 99(21): 13498-503, 2002 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-12370412

RESUMO

By using a cre-lox conditional knockout strategy, we report here the generation of androgen receptor knockout (ARKO) mice. Phenotype analysis shows that ARKO male mice have a female-like appearance and body weight. Their testes are 80% smaller and serum testosterone concentrations are lower than in wild-type (wt) mice. Spermatogenesis is arrested at pachytene spermatocytes. The number and size of adipocytes are also different between the wt and ARKO mice. Cancellous bone volumes of ARKO male mice are reduced compared with wt littermates. In addition, we found the average number of pups per litter in homologous and heterozygous ARKO female mice is lower than in wt female mice, suggesting potential defects in female fertility and/or ovulation. The cre-lox ARKO mouse provides a much-needed in vivo animal model to study androgen functions in the selective androgen target tissues in female or male mice.


Assuntos
Receptores Androgênicos/deficiência , Tecido Adiposo/anormalidades , Androgênios/fisiologia , Animais , Peso Corporal , Osso e Ossos/anormalidades , Feminino , Marcação de Genes , Genitália Masculina/anormalidades , Heterozigoto , Homozigoto , Integrases/genética , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Camundongos Transgênicos , Modelos Biológicos , Gravidez , Receptores Androgênicos/genética , Receptores Androgênicos/fisiologia , Caracteres Sexuais , Espermatogênese/genética , Espermatogênese/fisiologia , Testículo/anormalidades , Testosterona/sangue , Proteínas Virais/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...